...
机译:P2.01-013含有CD44 siRNA的HA-脂质体纳米载体作为靶向化学疗法至CD44相关的化学抑制剂非小细胞肺癌
Thoracic and Cardiovascular Surgery Korea University Guro Hospital;
Thoracic and Cardiovascular Surgery Korea University Guro Hospital;
Bio and Brain Engineering Korea Advanced Institute of Science and Technology;
Thoracic and Cardiovascular Surgery Korea University Guro Hospital;
Bio and Brain Engineering Korea Advanced Institute of Science and Technology;
Thoracic and Cardiovascular Surgery Korea University Guro Hospital;
机译:P2.01-013含有CD44 siRNA的HA-脂质体纳米载体作为靶向化学疗法至CD44相关的化学抑制剂非小细胞肺癌
机译:CD44的自定位敲低改善了化学抑制剂非小细胞肺癌细胞的顺铂敏感性
机译:CD44靶向化疗,使用沙利霉素和紫杉醇的聚合物纳米粒子共同根除乳腺癌干细胞和癌细胞
机译:表面工程氧化铈纳米粒子对靶向表达CD44的癌细胞有承诺
机译:在头颈部鳞状细胞癌中以纳米粒子靶向CD44:针对癌症干细胞的新型治疗策略
机译:靶向的抑制CD44和同时细胞死亡诱导的纳米药物在卵巢癌:siRNA和抗癌药物的最佳传递。
机译:表达CD44的非小细胞肺癌细胞具有丰富的干细胞样特性